|
The collaboration validates AI-ready card credentials, authentication and payment signals on Visa Intelligent Commerce, ensuring ecosystem readiness for secure, agent-initiated payments
SINGAPORE, Feb. 16, 2026 /PRNewswire/ -- DBS Bank, Southeast Asia's largest bank and Visa, a global leader in digital payments today announced their ongoing collaboration to drive the future of agent-initiated payments via a joint pilot under Visa Intelligent Commerce (VIC). VIC brings together a comprehensive suite of integrated APIs and a partner programme, utilising Visa's secure infrastructure to enable safe, transparent and consent-driven payments by AI agents, on behalf of consumers.
Through this collaboration with Visa, DBS is the first issuer in Asia Pacific to advance real-world agentic commerce use cases, marking a significant step in translating agentic commerce from concept to reality, as well as establishing the foundations for safe and scalable adoption across the region.
A Visa commissioned study showed that generative AI chatbots have quickly become mainstream among Singapore consumers, with usage reaching exceptionally high levels. Close to 77% of Singapore residents are already using generative AI tools such as chatbots in their daily lives, signalling rapid adoption across age groups. This momentum is also reflected in online shopping behaviours — with eight in 10 Singapore consumers now relying on AI assistance when shopping online. These insights highlight how deeply integrated AI has become in the digital habits of Singaporeans today.
Building on this momentum, DBS and Visa successfully demonstrated through a series of real-world food and beverage transactions that AI-powered agents can complete everyday tasks on behalf of customers using DBS/POSB credit and debit cards via secure, issuer-controlled flows. The collaboration will now enable DBS and Visa to explore a wider range of agentic commerce transactions, such as online shopping, travel bookings and more. These trials aim to make digital transactions more seamless for consumers, reduce manual steps and streamline payment processes – all while maintaining rigorous controls.
"AI agents are unlocking a new phase in digital payments, where routine transactions can be completed efficiently and reliably, helping customers save time and simplify everyday tasks," said Ananya Sen, Group Head of Regional Consumer Products, DBS Bank. "Our collaboration with Visa shows how agent-led payments can be deployed securely and safely at scale, giving customers confidence in how transactions are made in an AI environment. By building these capabilities across our regional footprint, we are shaping the next generation of cards and payments, setting new standards for intelligent, trusted and seamless commerce."
"This collaboration with DBS marks meaningful progress in advancing ecosystem readiness at a time when agentic commerce is rapidly evolving," said T.R. Ramachandran, Head of Products & Solutions, Asia Pacific at Visa. "Through Visa Intelligent Commerce and Trusted Agent Protocol, we're building the foundation that will make agentic commerce safe, secure and scalable — from AI‑ready credentials to advanced authentication. This sets the stage for how trusted, AI‑powered experiences will come to life for consumers and partners across the region."
As the collaboration progresses, DBS is strengthening its readiness for agent-led commerce by validating AI‑ready credentials[1], advanced authentication and intent‑driven transaction controls. With Visa Intelligent Commerce, the collaboration is shaping a framework where trust, accountability and customer choice are built into every transaction. This approach positions DBS and Visa to help define how agentic commerce can scale responsibly across the region, balancing innovation with resilience, as well as convenience with confidence.
| [1] AI‑ready credentials are secure, tokenised card details that trusted AI agents can use to make purchases safely on cardholders' behalf, protected by Visa's authentication checks, intent‑driven safeguards and issuer‑managed permissions |
About DBS
DBS is a leading financial services group in Asia with a presence in 19 markets. Headquartered and listed in Singapore, DBS is in the three key Asian axes of growth: Greater China, Southeast Asia and South Asia. The bank's "AA-" and "Aa1" credit ratings are among the highest in the world.
Recognised for its global leadership, DBS has been named "World's Best Bank" by Global Finance, "World's Best Bank" by Euromoney and "Global Bank of the Year" by The Banker. The bank is at the forefront of leveraging digital technology to shape the future of banking, having been named "World's Best Digital Bank" by Euromoney and the world's "Most Innovative in Digital Banking" by The Banker. In addition, DBS has been accorded the "Safest Bank in Asia" award by Global Finance for 17 consecutive years from 2009 to 2025.
DBS provides a full range of services in consumer, SME and corporate banking. As a bank born and bred in Asia, DBS understands the intricacies of doing business in the region's most dynamic markets.
DBS is committed to building lasting relationships with customers, as it banks the Asian way. Through the DBS Foundation, the bank creates impact beyond banking by uplifting lives and livelihoods of those in need. It provides essential needs to the underprivileged, and fosters inclusion by equipping the underserved with financial and digital literacy skills. It also nurtures innovative social enterprises that create positive impact.
With its extensive network of operations in Asia and emphasis on engaging and empowering its staff, DBS presents exciting career opportunities. For more information, please visit www.dbs.com.
About Visa
Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.
The collaboration validates AI-ready card credentials, authentication and payment signals on Visa Intelligent Commerce, ensuring ecosystem readiness for secure, agent-initiated payments
SINGAPORE, Feb. 16, 2026 /PRNewswire/ -- DBS Bank, Southeast Asia's largest bank and Visa, a global leader in digital payments today announced their ongoing collaboration to drive the future of agent-initiated payments via a joint pilot under Visa Intelligent Commerce (VIC). VIC brings together a comprehensive suite of integrated APIs and a partner programme, utilising Visa's secure infrastructure to enable safe, transparent and consent-driven payments by AI agents, on behalf of consumers.
Through this collaboration with Visa, DBS is the first issuer in Asia Pacific to advance real-world agentic commerce use cases, marking a significant step in translating agentic commerce from concept to reality, as well as establishing the foundations for safe and scalable adoption across the region.
A Visa commissioned study showed that generative AI chatbots have quickly become mainstream among Singapore consumers, with usage reaching exceptionally high levels. Close to 77% of Singapore residents are already using generative AI tools such as chatbots in their daily lives, signalling rapid adoption across age groups. This momentum is also reflected in online shopping behaviours — with eight in 10 Singapore consumers now relying on AI assistance when shopping online. These insights highlight how deeply integrated AI has become in the digital habits of Singaporeans today.
Building on this momentum, DBS and Visa successfully demonstrated through a series of real-world food and beverage transactions that AI-powered agents can complete everyday tasks on behalf of customers using DBS/POSB credit and debit cards via secure, issuer-controlled flows. The collaboration will now enable DBS and Visa to explore a wider range of agentic commerce transactions, such as online shopping, travel bookings and more. These trials aim to make digital transactions more seamless for consumers, reduce manual steps and streamline payment processes – all while maintaining rigorous controls.
"AI agents are unlocking a new phase in digital payments, where routine transactions can be completed efficiently and reliably, helping customers save time and simplify everyday tasks," said Ananya Sen, Group Head of Regional Consumer Products, DBS Bank. "Our collaboration with Visa shows how agent-led payments can be deployed securely and safely at scale, giving customers confidence in how transactions are made in an AI environment. By building these capabilities across our regional footprint, we are shaping the next generation of cards and payments, setting new standards for intelligent, trusted and seamless commerce."
"This collaboration with DBS marks meaningful progress in advancing ecosystem readiness at a time when agentic commerce is rapidly evolving," said T.R. Ramachandran, Head of Products & Solutions, Asia Pacific at Visa. "Through Visa Intelligent Commerce and Trusted Agent Protocol, we're building the foundation that will make agentic commerce safe, secure and scalable — from AI‑ready credentials to advanced authentication. This sets the stage for how trusted, AI‑powered experiences will come to life for consumers and partners across the region."
As the collaboration progresses, DBS is strengthening its readiness for agent-led commerce by validating AI‑ready credentials[1], advanced authentication and intent‑driven transaction controls. With Visa Intelligent Commerce, the collaboration is shaping a framework where trust, accountability and customer choice are built into every transaction. This approach positions DBS and Visa to help define how agentic commerce can scale responsibly across the region, balancing innovation with resilience, as well as convenience with confidence.
[1] AI‑ready credentials are secure, tokenised card details that trusted AI agents can use to make purchases safely on cardholders' behalf, protected by Visa's authentication checks, intent‑driven safeguards and issuer‑managed permissions
About DBS
DBS is a leading financial services group in Asia with a presence in 19 markets. Headquartered and listed in Singapore, DBS is in the three key Asian axes of growth: Greater China, Southeast Asia and South Asia. The bank's "AA-" and "Aa1" credit ratings are among the highest in the world.
Recognised for its global leadership, DBS has been named "World's Best Bank" by Global Finance, "World's Best Bank" by Euromoney and "Global Bank of the Year" by The Banker. The bank is at the forefront of leveraging digital technology to shape the future of banking, having been named "World's Best Digital Bank" by Euromoney and the world's "Most Innovative in Digital Banking" by The Banker. In addition, DBS has been accorded the "Safest Bank in Asia" award by Global Finance for 17 consecutive years from 2009 to 2025.
DBS provides a full range of services in consumer, SME and corporate banking. As a bank born and bred in Asia, DBS understands the intricacies of doing business in the region's most dynamic markets.
DBS is committed to building lasting relationships with customers, as it banks the Asian way. Through the DBS Foundation, the bank creates impact beyond banking by uplifting lives and livelihoods of those in need. It provides essential needs to the underprivileged, and fosters inclusion by equipping the underserved with financial and digital literacy skills. It also nurtures innovative social enterprises that create positive impact.
With its extensive network of operations in Asia and emphasis on engaging and empowering its staff, DBS presents exciting career opportunities. For more information, please visit www.dbs.com.
About Visa
Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
|
Lunit highlights enterprise AI adoption and FDA-cleared advancements at SBI 2026
SEOUL, South Korea, April 16, 2026 /PRNewswire/ -- At the Society of Breast Imaging (SBI) Annual Symposium, Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced accelerating clinical adoption across the U.S., a full-scale enterprise deployment of its AI-powered breast cancer ecosystem, and FDA clearance of its next-generation 3D mammography AI.
Lexington Clinic Adopts Full Breast Cancer Ecosystem
Lexington Clinic, Central Kentucky's largest and oldest physician-owned multi-specialty medical group (serving more than 350 providers), has implemented Lunit's complete AI-powered breast cancer ecosystem.
The deployment spans:
- Detection with Lunit INSIGHT® Breast Suite for mammography (MMG) and digital breast tomosynthesis (DBT)
- Quality optimization with Analytics™ and Volpara® Live™
- Volumetric breast density assessment with Volpara® Scorecard™
- Risk assessment with Risk Pathways™, integrated into clinical workflows
- Mammography tracking with Patient Hub™
The implementation signals a shift toward end-to-end AI integration across the breast care continuum—from risk to detection to quality—within a single software suite.
"Our goal is to deliver the highest standard of care while keeping workflows efficient and consistent," said Angie Hall, Breast Center Manager at Lexington Clinic. "Bringing risk, detection, and quality into one ecosystem improves coordination across our team and supports more confident, earlier decision-making for every patient."
Adoption Across the Americas Surpasses 330 Sites
Over the past year, Lunit has expanded to more than 330 screening sites across the Americas, supporting approximately one million screening mammograms annually.
The milestone highlights a broader industry shift: while AI validation is well established, real-world adoption at scale is now the key differentiator.
"Across the Americas, we're seeing a clear move from evaluation to enterprise-wide implementation," said Craig Hadfield, CEO of Lunit International. "Providers are moving beyond pilots into daily clinical use. Reaching more than 330 sites and supporting one million screenings annually reflects sustained, real-world adoption—where AI is delivering value in routine practice."
Real-World Clinical Impact: Radiology Consultants of Iowa
At Radiology Consultants of Iowa (RCI), one of the largest radiology groups in the state, Lunit INSIGHT DBT is already embedded in routine clinical workflows, demonstrating the impact of AI beyond the study setting.
"After six months of using AI in our daily workflow, it's become part of how we read," said Robert J. Dolan, DO, breast imaging specialist at RCI. "It gives us added confidence—especially in subtle cases—and helps ensure we don't miss what matters most."
At SBI, Dr. Dolan will review cases each day in Lunit's booth, highlighting where AI positively impacts his interpretation, giving attendees a chance to discuss real-world adoption.
FDA Clearance of Next-Generation 3D AI with Current-Prior Comparison
As providers move into routine AI use, flexibility in how algorithms are deployed is becoming increasingly important. Lunit announced that Version 1.2 of its 3D mammography algorithm has received clearance from the U.S. Food and Drug Administration (FDA).
The updated version introduces current-prior comparisons and multiple operating thresholds, enabling providers to tailor AI performance to their clinical environment.
Key enhancements include:
- Current-prior comparison (CPC) provides AI findings for the current exam and up to two prior exams
- Three selectable thresholds, supporting different sensitivity and specificity trade-offs
- Access to Volpara® Scorecard™ volumetric breast density measures along with AI scores
These updates reinforce Lunit's focus on practical usability—giving clinicians greater control over how AI is applied in daily practice.
###
About Lunit
Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis—empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum.
Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT Breast Suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while the Lunit SCOPE platform is used in research partnership with global pharma and laboratory leaders for biomarker research, and companion diagnostic development.
Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact—for patients, clinicians, and researchers alike. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io.
Lunit highlights enterprise AI adoption and FDA-cleared advancements at SBI 2026
SEOUL, South Korea, April 16, 2026 /PRNewswire/ -- At the Society of Breast Imaging (SBI) Annual Symposium, Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced accelerating clinical adoption across the U.S., a full-scale enterprise deployment of its AI-powered breast cancer ecosystem, and FDA clearance of its next-generation 3D mammography AI.
Lexington Clinic Adopts Full Breast Cancer Ecosystem
Lexington Clinic, Central Kentucky's largest and oldest physician-owned multi-specialty medical group (serving more than 350 providers), has implemented Lunit's complete AI-powered breast cancer ecosystem.
The deployment spans:
- Detection with Lunit INSIGHT® Breast Suite for mammography (MMG) and digital breast tomosynthesis (DBT)
- Quality optimization with Analytics™ and Volpara® Live™
- Volumetric breast density assessment with Volpara® Scorecard™
- Risk assessment with Risk Pathways™, integrated into clinical workflows
- Mammography tracking with Patient Hub™
The implementation signals a shift toward end-to-end AI integration across the breast care continuum—from risk to detection to quality—within a single software suite.
"Our goal is to deliver the highest standard of care while keeping workflows efficient and consistent," said Angie Hall, Breast Center Manager at Lexington Clinic. "Bringing risk, detection, and quality into one ecosystem improves coordination across our team and supports more confident, earlier decision-making for every patient."
Adoption Across the Americas Surpasses 330 Sites
Over the past year, Lunit has expanded to more than 330 screening sites across the Americas, supporting approximately one million screening mammograms annually.
The milestone highlights a broader industry shift: while AI validation is well established, real-world adoption at scale is now the key differentiator.
"Across the Americas, we're seeing a clear move from evaluation to enterprise-wide implementation," said Craig Hadfield, CEO of Lunit International. "Providers are moving beyond pilots into daily clinical use. Reaching more than 330 sites and supporting one million screenings annually reflects sustained, real-world adoption—where AI is delivering value in routine practice."
Real-World Clinical Impact: Radiology Consultants of Iowa
At Radiology Consultants of Iowa (RCI), one of the largest radiology groups in the state, Lunit INSIGHT DBT is already embedded in routine clinical workflows, demonstrating the impact of AI beyond the study setting.
"After six months of using AI in our daily workflow, it's become part of how we read," said Robert J. Dolan, DO, breast imaging specialist at RCI. "It gives us added confidence—especially in subtle cases—and helps ensure we don't miss what matters most."
At SBI, Dr. Dolan will review cases each day in Lunit's booth, highlighting where AI positively impacts his interpretation, giving attendees a chance to discuss real-world adoption.
FDA Clearance of Next-Generation 3D AI with Current-Prior Comparison
As providers move into routine AI use, flexibility in how algorithms are deployed is becoming increasingly important. Lunit announced that Version 1.2 of its 3D mammography algorithm has received clearance from the U.S. Food and Drug Administration (FDA).
The updated version introduces current-prior comparisons and multiple operating thresholds, enabling providers to tailor AI performance to their clinical environment.
Key enhancements include:
- Current-prior comparison (CPC) provides AI findings for the current exam and up to two prior exams
- Three selectable thresholds, supporting different sensitivity and specificity trade-offs
- Access to Volpara® Scorecard™ volumetric breast density measures along with AI scores
These updates reinforce Lunit's focus on practical usability—giving clinicians greater control over how AI is applied in daily practice.
###
About Lunit
Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis—empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum.
Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT Breast Suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while the Lunit SCOPE platform is used in research partnership with global pharma and laboratory leaders for biomarker research, and companion diagnostic development.
Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact—for patients, clinicians, and researchers alike. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Lunit Surpasses 330+ Sites and 1M Annual Screenings as Breast Imaging AI Moves into Clinical Practice
